Abstract:Background: Natural products have been an exemplary source of new drugs as they have served as direct or indirect precursors for many currently available medicines. The natural product beta-elemene has been used clinically in the treatment of various cancers; however, its efficacy is hampered by its poor solubility and bioavailability. Methods: An aldehyde metabolite of beta-elemene, 13-beta-elemenal, was further identified and proved to exhibit significantly better anti-proliferative activity than beta-elemene. A series of prodrug-like 13- and 14-substituted ester derivatives, as well as their alcohol and aldehyde intermediates, were rational designed, synthesized and biologically evaluated. Results: The intermediates and ester derivatives of beta-elemene displayed comparable to better anti-proliferative activity on human cancer cell lines (A549, HepG-2 and U87). Notably, ester compounds 10d, 10m-o, 10s, 10t, 13d, 13h and 13m-o were superior over beta-elemene in their antiproliferation effects, while the predicted in vivo metabolites of the designed ester compounds, 13 beta-elemental (8) and 14-beta-elemental (11), demonstrated the most potent anti- proliferative effect. Conclusion: Most of the esters displayed better antitumor effects than beta-elemene, which were predicted to play more significant roles in the in vivo treatment by being metabolized continuously to beta-elemental. More importantly, these compounds showed better drug-like properties, such as decreased LogP values and improved solubility.

Synthesis and in vitro antitumor activity of β-elemene monosubstituted amine derivatives

Synthesis, Characterization, and in Vitro Antiproliferative Activity of Novel Β-Elemene Monosubstituted Derivatives

Synthesis and in vitro anti-proliferative activity of β-elemene monosubstituted derivatives in HeLa cells mediated through arrest of cell cycle at the G1 phase

Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.

Synthesis of Flavone Derivatives via N-Amination and Evaluation of Their Anticancer Activities

Novel Hybrids of Natural Β-Elemene Bearing Isopropanolamine Moieties: Synthesis, Enhanced Anticancer Profile, and Improved Aqueous Solubility.

Design, Synthesis, and in Vitro Antitumor Evaluation of Novel Phenylaminopyrimidine Derivatives.

Synthesis and Anti-Tumor Activity Research of a Novel Series of 3-Amidebenzamide Derivatives

Rational Design, Synthesis and Biological Evaluation of Novel Derivatives Based on in Vivo Metabolism of Natural Product Β-Elemene

Progress of β-Elemene and its Derivatives

Synthesis and Antitumor Evaluation of a Novel Series of Triaminotriazine Derivatives.

Synthesis and antitumor activity evaluation of the derivatives of 1,2,4 - triazole -5 - thione bis - schiff base

Synthesis and Antitumor Activity of Α-Aminophosphonate Derivatives Containing Thieno[2,3-D]pyrimidines

Synthesis and Anti-tumor Activity of Novel 2-Amino-1,3,4-thiadiazole Derivativers

Synthesis and antiproliferative activities of novel 2-substituted-4-aminothieno[3,2-d]pyrimidine derivatives

Synthesis and Cytotoxicity of Oleanolic Acid/N-aryl-N'-hydroxyguanidine Hybrids

Synthesis and biological evaluation of the novel antitumor agent 3'-monosubstituted chalcone derivatives

The synthesis and anti-tumor activity research of a novel quinazoline derivatives

Synthesis and antitumor activity of 17-carboxylic acid modified amide derivatives of 23-hydroxy betulinic acid

Synthesis and in vitro antitumor activities of xanthone derivatives containing 1,4-disubstituted-1,2,3-triazole moiety

[Design, Synthesis and Antitumor Activities of Novel E-substituted 2,3-Diaryl Propenoic Acyloxy Phosphonate Derivatives].